Information Library
Results for: Product Development & Commercialization - Late Phase
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Quintiles Strengthens Late Phase Offerings with Acquisition of Outcome Sciences, Inc.
Press Release — October 19, 2011 – With late phase (Phase IIIB and Phase IV) research becoming increasingly important to multiple healthcare stakeholders, Quintiles has acquired Outcome Sciences, Inc. (Outcome).
-
Quintiles Approach to "Real-World" Research helps Biopharma Customers Drive Competitive Advantage
Press Release — September 19, 2011 –A perfect storm of stakeholder demands, unprecedented data access, new data channels and technologies is driving a dramatic shift in research methodologies among biopharmaceutical companies, according to a new report from Quintiles.
-
Late Phase Research
Brochure — March 14, 2011
Integrated solutions to define, demonstrate and communicate product value -
Exclusive Report From Scientific American
Hear from the Experts — November 9, 2010
In-depth insights on every angle of the changing health landscape - brought to you by Quintiles Get the report today. -
Executive Vision Forum 2010: Convergence of Stakeholders
Presentation — July 9, 2010
A Holistic Approach to Patient Outcomes - Brian Sweet, CPO, WellPoint. Presentation about the convergence of stakeholders. -
Targeting Oncology
Brochure — June 2, 2010
Learn more about Quintiles leadership in oncology product development and commercialization. -
PharmAsia News Article Reprint
Media Coverage — March 1, 2010
Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News.
Page 1 of 1 (7 results)
